KIMCo

Korea Innovative
Medicines Consortium

  • KIMCo
    Collaboration with Translational
    Research for Innovative Medicine

    Hongreung bio-cluster

    view more
  • KIMCo
    Collaboration with Innovative Pharmaceutical
    Bio Companies in Europe

    Korea-Europe Biomedical Partnership Project

    view more
  • Translational Research for Innovative Medicine : Hongreung bio-cluster
    • Overview

      • This project is carried out with Hongreung bio-cluster and supports operating translational research partnership to be matched and commercialized.

    • Purpose

      • To match great technology with a pharmaceutical company
      ※ It Supports research support projects of the Hongneung Special Zone Project Group and private funds (Hongneung Fund and Seoul Metropolitan Bio Fund).

      arrow Promoting commercialization of translational research and preemptive acquisition of excellent new drug pipelines.
    • Schedule

      • May / Open IR, Technical Briefing and Initiation

  • 2022 Korea-Europe Biomedical Partnership Project
    • Overview

      • The project supports Korean pharmaceutical companies form a "demand-based collaborative relationship" with global pharmaceutical companies, innovative Biotech companies, and bio-clusters in Europe.

      • Department : KIMCo, KPBMA, KOTRA, KDDF

    • Purpose

      • To establish a bidirectional partnership between Korea and Europe
      - Research&Technology transfer/Co-development/Investment
      - Export and Import of drug substance and drug product/Consignment production

    • Schedule

      • May 2nd (Monday)~4th (Wed) / Webinar, 1:1 online meeting

Top